Our mission is to support countries to address drug-resistant bacterial infections by expanding access to essential antibiotics in a sustainable, equitable and appropriate way by optimising antibiotic portfolios, creating efficiencies and supply security, enhancing information transparency and Stewarding antibiotic delivery and access.
Our key objectives and interventions
-
Drug portfolio optimization to consolidate market around the most effective treatment options based on needs of the country.
Related document:
-
Collect and collate antibiotic and supplier market intelligence to improve decision-making on procurement
Coordinate an Antibiotic Market Working Group to share market intelligence and coordinate response to supply threats.
-
Apply an antibiotic forecasting model to support forecasting demand, pooling and contracting with suppliers.
Increase demand predictability and attractiveness for suppliers by aggregating demand across countries.
Establish pooled or coordinated procurement through partnering with existing procurement mechanisms.
Address recurrent antibiotic shortages, including forecasting demand and regulatory or policy interventions to address shortages.
Deploy economic tools to incentivize suppliers to enter country markets and support country purchasing through catalytic financing methods.
Related documents:
-
Support product introduction pathways, stewardship activities along the value chain, collect evidence of impact and best practices
Work with regional/country partners to support these activities
